Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Agile, Algernon, Allena, Autolus, Azurrx, Biocryst, Citius, CTI, Curevac, Deciphera, Edesa, Fergene, Galecto, Hookipa, Imago, Istari, Kiniksa, Marinomed, Moderna, Neoimmunetech, Novavax, PTC, Valirx, Verastem.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytosorbents, Moleculight.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Ascentage, Celltrion, Equillium, Inmed, Karyopharm, Medicinova, Urovant.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: NaviFUS.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3Sbio, Amarin, Ampio, Astrazeneca, Beigene, Bellerophon, Biolinerx, Biontech, Bioshin, Boehringer Ingelheim, CASI, Clear Creek, Cytodyn, Edding, Eisai, Gannex, Gemvax & Kael, Helixmith, Idorsia, Immutep, Imugene, Innovent, Kangpu, Kazia, Marinomed, Merck, Molecular Partners, Mydecine Innovations, Organicell Regenerative Medicine, Pfizer, Redhill, Sagimet, Selecta, Trippbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apnimed, Bausch, Capricor, Celularity, City of Hope, GSK, Kubota, Oramed, Principia, RDIF, Reithera, Strongbridge, Targovax, Tolmar.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nuvaira.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 3Sbio, Algernon, Arcutis, Astrazeneca, Bellerophon, Bioshin, Cytodyn, Dnatrix, Eisai, Faron, Gemvax & Kael, Idorsia, IGC, Immunocore, Imugene, Innovent, Inovio, Karyopharm, Maplight, Molecular Partners, Neurana, Pfizer, PMV, Silicon Therapeutics, Saniona, Selecta, Syndevrx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocept.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amarin, Clear Creek, Glycostem, Inovio, Marinomed, Redhill.